Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 1
2014 1
2015 1
2018 3
2019 2
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
A Review of Biologically Active Oxime Ethers.
Kosmalski T, Kupczyk D, Baumgart S, Paprocka R, Studzińska R. Kosmalski T, et al. Molecules. 2023 Jun 28;28(13):5041. doi: 10.3390/molecules28135041. Molecules. 2023. PMID: 37446703 Free PMC article. Review.
A Review of the Biological Activity of Amidrazone Derivatives.
Paprocka R, Wiese-Szadkowska M, Kosmalski T, Frisch D, Ratajczak M, Modzelewska-Banachiewicz B, Studzińska R. Paprocka R, et al. Among authors: kosmalski t. Pharmaceuticals (Basel). 2022 Sep 30;15(10):1219. doi: 10.3390/ph15101219. Pharmaceuticals (Basel). 2022. PMID: 36297331 Free PMC article. Review.
11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases.
Kupczyk D, Bilski R, Kozakiewicz M, Studzińska R, Kędziora-Kornatowska K, Kosmalski T, Pedrycz-Wieczorska A, Głowacka M. Kupczyk D, et al. Among authors: kosmalski t. Int J Mol Sci. 2022 Aug 11;23(16):8984. doi: 10.3390/ijms23168984. Int J Mol Sci. 2022. PMID: 36012251 Free PMC article. Review.
The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial.
Niezgoda A, Winnicki A, Kosmalski T, Kowaliszyn B, Krysiński J, Czajkowski R. Niezgoda A, et al. Among authors: kosmalski t. Trials. 2019 Jan 25;20(1):78. doi: 10.1186/s13063-018-3168-4. Trials. 2019. PMID: 30683146 Free PMC article.
16 results